New shot aims to boost blood cells in cancer patients
NCT ID NCT06534255
First seen Nov 28, 2025 · Last updated May 15, 2026 · Updated 18 times
Summary
This early-stage study tests a new drug called MegaLT for people whose platelet counts stay dangerously low after chemotherapy, radiation, or a stem cell transplant. The main goals are to check safety and see if it helps raise platelet levels. The trial involves 10 participants aged 4 to 75.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Hefei, Anhui, 230036, China
Conditions
Explore the condition pages connected to this study.